Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon J Furney

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Journal of Alzheimer'S Disease : JAD|October 6, 2011
Combinatorial markers of mild cognitive impairment conversion to Alzheimer's disease--cytokines and MRI measures together predict disease progressionSimon J Furney, Deborah Kronenberg, Andrew Simmons, et al.
Nature Communications|May 13, 2021
Ultraviolet light-induced collagen degradation inhibits melanoma invasionTimothy Budden, Caroline Gaudy-Marqueste, Andrew Porter, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 2, 2021
Female Immunity Protects from Cutaneous Squamous Cell CarcinomaTimothy Budden, Caroline Gaudy-Marqueste, Sarah Craig, et al.
Pigment Cell & Melanoma Research|May 15, 2012
Genomic characterisation of acral melanoma cell linesSimon J Furney, Samra Turajlic, Kerry Fenwick, et al.
Genome Research|December 21, 2011
Whole genome sequencing of matched primary and metastatic acral melanomasSamra Turajlic, Simon J Furney, Maryou B Lambros, et al.
Journal of Alzheimer'S Disease : JAD|October 9, 2012
A blood gene expression marker of early Alzheimer's diseaseKatie Lunnon, Martina Sattlecker, Simon J Furney, et al.
Oncotarget|October 25, 2016
The impact of ERBB-family germline single nucleotide polymorphisms on survival response to adjuvant trastuzumab treatment in HER2-positive breast cancerSinead Toomey, Stephen F Madden, Simon J Furney, et al.
Cancer Discovery|December 31, 2015
Application of Sequencing, Liquid Biopsies, and Patient-Derived Xenografts for Personalized Medicine in MelanomaMaria Romina Girotti, Gabriela Gremel, Rebecca Lee, et al.
Cancer Discovery|February 6, 2026
Expression of Concern: Application of Sequencing, Liquid Biopsies, and Patient-Derived Xenografts for Personalized Medicine in MelanomaMaria R Girotti, Gabriela Gremel, Rebecca Lee, et al.
NPJ Breast Cancer|September 27, 2023
Predictive modelling of response to neoadjuvant therapy in HER2+ breast cancerNicola Cosgrove, Alex J Eustace, Peter O'Donovan, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Journal of Alzheimer'S Disease : JAD|October 6, 2011
Combinatorial markers of mild cognitive impairment conversion to Alzheimer's disease--cytokines and MRI measures together predict disease progressionSimon J Furney, Deborah Kronenberg, Andrew Simmons, et al.
Nature Communications|May 13, 2021
Ultraviolet light-induced collagen degradation inhibits melanoma invasionTimothy Budden, Caroline Gaudy-Marqueste, Andrew Porter, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 2, 2021
Female Immunity Protects from Cutaneous Squamous Cell CarcinomaTimothy Budden, Caroline Gaudy-Marqueste, Sarah Craig, et al.
Pigment Cell & Melanoma Research|May 15, 2012
Genomic characterisation of acral melanoma cell linesSimon J Furney, Samra Turajlic, Kerry Fenwick, et al.
Genome Research|December 21, 2011
Whole genome sequencing of matched primary and metastatic acral melanomasSamra Turajlic, Simon J Furney, Maryou B Lambros, et al.
Journal of Alzheimer'S Disease : JAD|October 9, 2012
A blood gene expression marker of early Alzheimer's diseaseKatie Lunnon, Martina Sattlecker, Simon J Furney, et al.
Oncotarget|October 25, 2016
The impact of ERBB-family germline single nucleotide polymorphisms on survival response to adjuvant trastuzumab treatment in HER2-positive breast cancerSinead Toomey, Stephen F Madden, Simon J Furney, et al.
Cancer Discovery|December 31, 2015
Application of Sequencing, Liquid Biopsies, and Patient-Derived Xenografts for Personalized Medicine in MelanomaMaria Romina Girotti, Gabriela Gremel, Rebecca Lee, et al.
Cancer Discovery|February 6, 2026
Expression of Concern: Application of Sequencing, Liquid Biopsies, and Patient-Derived Xenografts for Personalized Medicine in MelanomaMaria R Girotti, Gabriela Gremel, Rebecca Lee, et al.
NPJ Breast Cancer|September 27, 2023
Predictive modelling of response to neoadjuvant therapy in HER2+ breast cancerNicola Cosgrove, Alex J Eustace, Peter O'Donovan, et al.
Pageof 5